TFEB-vacuolar ATPase signaling regulates lysosomal function and microglial activation in tauopathy.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
06 Feb 2023
06 Feb 2023
Historique:
pubmed:
18
2
2023
medline:
18
2
2023
entrez:
17
2
2023
Statut:
epublish
Résumé
Transcription factor EB (TFEB) mediates gene expression through binding to the Coordinated Lysosome Expression And Regulation (CLEAR) sequence. TFEB targets include subunits of the vacuolar ATPase (v-ATPase) essential for lysosome acidification. Single nucleus RNA-sequencing (snRNA-seq) of wild-type and PS19 (Tau) transgenic mice identified three unique microglia subclusters in Tau mice that were associated with heightened lysosome and immune pathway genes. To explore the lysosome-immune relationship, we specifically disrupted the TFEB-v-ATPase signaling by creating a knock-in mouse line in which the CLEAR sequence of one of the v-ATPase subunits,
Identifiants
pubmed: 36798205
doi: 10.1101/2023.02.06.527293
pmc: PMC9934527
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIA NIH HHS
ID : P01 AG066606
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG020670
Pays : United States
Organisme : NIA NIH HHS
ID : R00 AG062746
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG062257
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS093652
Pays : United States
Commentaires et corrections
Type : UpdateIn
Déclaration de conflit d'intérêts
Competing interests The authors declare no competing interests.